Author

A. Ramiro

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Benguria Filippini· 1 shared A. Dopazo· 1 shared A. Triguero Martinez· 1 shared A. V. Marin· 1 shared C. Delgado Alfaro· 1 shared D. Calzada Fraile· 1 shared D. Ulgiati· 1 shared E. Martin-Gayo· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Benguria Filippini

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MYC directly transactivates CR2/CD21, the receptor of the Epstein-Barr virus, and enhances the viral infection of Burkitt lymphoma cells

E. Molina, L. Garcia-Gutierrez, V. Junco, M. Perez-Olivares, V. G de Yebenes, R. Blanco, L. Quevedo, J. C. Acosta, A. V. Marin, D. Ulgiati, R. Merino, I. Varela, J. R. Regueiro, I. Moreno de Alboran, A. Ramiro, J. Leon

This paper identifies CR2/CD21 as a direct target of MYC and shows that MYC enhances EBV infection in Burkitt lymphoma cells.

bioRxiv · Dec 28, 2022 · PreprintCancer Biology

Antiviral State of CD1c+ cDC contributes to Increased Maturation and Activation of Cytotoxic Natural Killer cells in Sjogrens Syndrome

I. Sanchez Cerrillo, M. Calvet Mirabent, A. Triguero Martinez, D. Calzada Fraile, C. Delgado Alfaro, M. Valdivia, M. ramirez-Huesca, E. Vazquez de Luis, A. Benguria Filippini, R. Moreno Vellisca, M. M. Adrados, H. de la Fuente, I. Tsukalov, E. Roy Vallejo, A. Ramiro, , E. Martin-Gayo

The paper identifies CD1c+ cDCs in pSS patients that enhance NK cell activation through antiviral IFN signatures and ligands for NK receptors, contributing to disease pathology.

bioRxiv · Mar 13, 2022 · PreprintImmunology